Botox Maker Settles Federal Marketing Charges
Botox manufacturer Allergan has agreed to plead guilty and pay $600 million to settle federal criminal and civil charges for marketing botox for uses not approved by the FDA, such as pain and headache.
Botox manufacturer Allergan has agreed to plead guilty and pay $600 million to settle federal criminal and civil charges for marketing botox for uses not approved by the FDA, such as pain and headache.